44 Furthermore, anergic cells Typically keep a greater susceptibility to apoptosis unless anti-apoptotic proteins including BCL2 are overexpressed, as is the case for CLL cells.45 Without a doubt, most key therapeutic advances transpiring in the final decade are connected with the inhibition of BCR and BCL2-mediated signaling.Kami menawarkan berbag